| Literature DB >> 27987732 |
Hossein Ahmadian1, Ehsan Hashemi2, Omid Akhavan3, Mehdi Shamsara4, Mehrdad Hashemi1, Abbas Farmany5, Morteza Daliri Joupari4.
Abstract
Recent studies showed that a large amount of graphene oxide accumulated in kidney and liver when it injected intravenously. Evaluation of lethal and apoptosis gene expression in these tissues, which are under stress is very important. In this paper the in vivo dose-dependent effects of graphene oxide and reduced graphene oxide nanoplatelets on kidney and liver of mice were studied. Balb/C mice were treated by 20mg/kg body weight of nanoplatelets. Molecular biology analysis showed that graphene nanoplatelets injected intravenously lead to overexpression of BAX gene in both kidney and liver tissues (P≥0.01). In addition these nanoparticles significantly increase BCL2 gene expression in both kidney and liver tissues (P≥0.05). Graphene significantly increase level of SGPT in groups 1 (220.64±13), 2 (164.44±9.3) in comparison to control group (P≤0.05). Also in comparison with control group (148.11±10.4), (P≤0.05), the level of SGOT in groups 1(182.01±12.6) and 2 (178.2±2.2) significantly increased.Entities:
Keywords: Apoptosis; Graphene; Kidney; Liver; Mouse
Mesh:
Substances:
Year: 2016 PMID: 27987732 DOI: 10.1016/j.msec.2016.09.073
Source DB: PubMed Journal: Mater Sci Eng C Mater Biol Appl ISSN: 0928-4931 Impact factor: 7.328